<bill session="117" type="h" number="7166" updated="2022-12-29T22:03:48Z">
  <state datetime="2022-03-18">REFERRED</state>
  <status>
    <introduced datetime="2022-03-18"/>
  </status>
  <introduced datetime="2022-03-18"/>
  <titles>
    <title type="display">Make Medicine in America Again Act</title>
    <title type="short" as="introduced">Make Medicine in America Again Act</title>
    <title type="official" as="introduced">To amend the Internal Revenue Code of 1986 to provide for extended expensing of pharmaceutical manufacturing property, and for other purposes.</title>
  </titles>
  <sponsor bioguide_id="M001195"/>
  <cosponsors>
    <cosponsor bioguide_id="T000483" joined="2022-05-19"/>
  </cosponsors>
  <actions>
    <action datetime="2022-03-18">
      <text>Introduced in House</text>
    </action>
    <action datetime="2022-03-18" state="REFERRED">
      <text>Referred to the House Committee on Ways and Means.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Taxation"/>
  </subjects>
  <amendments/>
  <summary date="2022-03-23T14:52:39Z" status="Introduced in House">Make Medicine in America Again Act

This bill provides tax incentives for the manufacture of pharmaceutical property, equipment, buildings, or facilities in the United States. Specifically it allows bonus depreciation for such property and a business-related tax credit for 50% of expenditures for (1) wages for services performed in a U.S. pharmaceutical manufacturing business, (2) the tangible personal property of such a business, and (3) any direct or indirect costs paid or incurred in a U.S. pharmaceutical manufacturing business.</summary>
</bill>
